FDA - Intent to Sole Source Molecular Operating Environment

SOL #: 7571TE26Q00038 Combined Synopsis/SolicitationSole Source

Overview

Buyer

Health And Human Services
Office Of The Assistant Secretary For Financial Resources (Asfr)
OMAS STRATEGIC BUYING CENTER - INFORMATION TECHNOLOGY
Rockville, MD, 20857, United States

Place of Performance

Silver Spring, MD

NAICS

Software Publishers (513210)

PSC

Application Development Software Delivered By Perpetual License, Consisting Of Analysis, Design, Development, Code, Test And Release Packages Associated With Application Development Projects. (7A20)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 9, 2026
2
Submission Deadline
Jun 16, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The U.S. Food and Drug Administration (FDA), specifically the Division of Applied Regulatory Science (DARS), intends to award a sole source contract to Chemical Computing Group ULC for the Molecular Operating Environment (MOE) software. This procurement aims to enhance DARS's analytical capabilities for three-dimensional (3D) structural analysis and representation, which is crucial for evaluating adverse drug reactions that cannot be adequately assessed through 2D approaches alone. Capability statements from other potential sources are due by June 16, 2026.

Scope of Requirement

The requirement is for the Molecular Operating Environment (MOE), a comprehensive cheminformatics and molecular modeling software platform. This software is essential for:

  • Conducting robust evaluations of adverse drug reactions.
  • Enabling 3D structural analysis and representation.
  • Providing customizable molecular docking models.
  • Updating computational models with chemical descriptors.
  • Supporting chemical database management.
  • Modeling diverse types of molecules and molecular interactions (organic, metallic, biomolecules).

Contract & Timeline

  • Type: Notice of Intent to Sole Source (not a solicitation)
  • Intended Awardee: Chemical Computing Group ULC
  • Justification: FAR 6.103-1 (Only one responsible source) due to unique capabilities, licensing agreements, and warranty coverage.
  • Period of Performance: A base year (June 29, 2026 - June 28, 2027) plus four one-year option periods, extending through June 28, 2031.
  • Set-Aside: None (Sole Source)
  • Capability Statement Due: June 16, 2026, by 12:00 PM EST
  • Published: June 9, 2026

Additional Notes

This notice is for informational purposes only and is not a solicitation or a request for offers. The Government is not obligated to acknowledge receipt of information or provide feedback. A determination to not compete the procurement is solely at the Government's discretion. Information received will be used to assess the possibility of a competitive procurement.

People

Points of Contact

Carlton TaylorPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jun 9, 2026
FDA - Intent to Sole Source Molecular Operating Environment | GovScope